The Susceptibility of Low Density Lipoprotein to Chemical Oxidation is Closely Related to Proneness to Biological Modification

References

• Hamsten A. Apolipoproteins, dyslipoproteinaemia and premature Coronary Heart Disease. Acta Medica Scandinavica 1988; 223: 389–403
   PubMedGoogle Scholar
• Hessler J. R., Robertson A. L., Chisholm G. M. LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture. Atherosclerosis 1979; 32: 213–229
   PubMed Web of Science ®Google Scholar
• Van Hinsbergh M. V.W. LDL Cytotoxicity. The state of the art. Atherosclerosis 1984; 53: 113–118
   PubMed Web of Science ®Google Scholar
• Evensen S. A.Galdal K. S., Nielsen E. LDL-induced cytotoxicity and its inhibition by anti-oxidant treatment in cultured human endothelial cells and fibroblasts. Atherosclerosis 1983; 49: 23–30
   PubMed Web of Science ®Google Scholar
• Cathcart M. K., McNally A. K., Morel D. W., Chishol G. M.m. Superoxide anion participation in human monocyte-mediated oxidation of low density lipoprotein and conversion of low density lipoprotein to a cytotoxin. Journal of Immunology 1989; 142: 1963–69
   PubMed Web of Science ®Google Scholar
• Partasarathy S., Weiland E., Steinberg D. A role for endothelial cell lipooxygenase in the oxidative modification of low density lipoprotein. Proceedings of the National Academy of Sciences, USA 1989; 86: 1046–50
   PubMed Web of Science ®Google Scholar
• Henriksen T., Mahoney E. M., Steinberg D. Enhanced macrophage degradation of biological modified low density lipoprotein. Arteriosclerosis 1983; 3: 149–159
   PubMedGoogle Scholar
• Palinsky W., Rosenfeld M., Ylä-Herttuala E., Gurtner G. C., Socher S. S., Butler S. W., Parthasarathy S., Carew T. E., Steinberg D., Witzum J. L. Low density lipoprotein undergoes modification in vivo. Proceedings of the National Academy of Sciences, USA 1989; 86: 1372–76
   PubMed Web of Science ®Google Scholar
• Kita T., Nagano Y., Yokode M., Ishii K., Kume N., Ooshima A., Yoshida H., Kawai C. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proceedings of the National Academy of Sciences, USA 1987; 84: 5928–31
   PubMed Web of Science ®Google Scholar
• Carew T. E., Schwenke D. C., Steinberg D. Antiatherogenic effects of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic (WHHL) rabbit. Proceedings of the National Academy of Sciences, USA 1987; 84: 7725–29
   PubMed Web of Science ®Google Scholar
• Esterbauer H., Striegl G., Puhl H., Rothender M. Continous monitoring of in vitro oxidation of human low density lipoprotein. Free Radical Research Communication 1989; 6: 67–75
   PubMed Web of Science ®Google Scholar
• Sundström C., Nilsson K. Establishment and characterization of a human histiocytic lymphoma cell line (U 937). International Journal of Cancer 1976; 7: 565–77
   Google Scholar
• Esfahani M., Scerbo L., Devlin T. A requirement for cholesterol and its structural features for a human macrophage-like cell line. Journal of Biological Chemistry 1984; 25: SI–91
   Google Scholar
• Frostegård J., Hamsten A., Gidlund M., Nilsson J. Low density lipoprotein-induced growth of U937 cells: a novel method to determine the receptor binding properties of low density lipoprotein. Journal of Lipid Research 1990; 31: 37–44
   PubMed Web of Science ®Google Scholar
• Cathcart M. K., Chisholm G. M., McNally A. K., Morel D. W. Oxidative modification of low density lipoprotein (LDL) by activated human monocytes and the cell lines U937 and HL60 In Vitro. Cell Developmental Biology 1988; 24: 1001–8
   Google Scholar
• Carlson K. Lipoprotein fractionation. Association of Clinical Pathology 1973; 5: 32–37
   Google Scholar
• Redgrave T. G., Roberts D. C.K., West C. E. Separation of plasma lipoproteins by density gradient ultracentrifugation. Analytical Biochemistry 1975; 65: 42–52
   PubMed Web of Science ®Google Scholar
• Yagi K. Short communications. A simple fluorometric assay for lipoperoxide in blood plasma. Biochemical Medicine 1976; 15: 212–216
   PubMed Web of Science ®Google Scholar
• Regnström J., Walldius G., Carlson L. A., Nilsson J. Effect of probucol treatment on oxidation of low density lipoprotein isolated from hypercholesterolemic patients. Atherosclerosis 1990; 82: 43–51
   PubMed Web of Science ®Google Scholar
• Cathcart M. K., McNally A. K., Morel D. W., Chisolm G. M. Superoxide anion participation in human monocyte-mediated oxidation of low-density lipoprotein and conversion of low-density lipoprotein to a cytotoxin. The Journal of Immunology 1989; 142: 1963–1969
   PubMed Web of Science ®Google Scholar
• Jessup W., Simpson L A., Dean R. T. Does superoxide radical have a role in macrophage-mediated oxidative modification of LDL?. Atherosclerosis 1993; 99(1)107–120
   PubMed Web of Science ®Google Scholar
• Steinberg D., Parthasarathy S., Carew T. E., Khoo J. C., Witztum J. L. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. New England Journal of Medicine 1989; 320: 915–924
   PubMed Web of Science ®Google Scholar
• Salonen J. T., Salonen R., Seppanen K., Kantola M. Relationship of serum selenium and antioxidants to plasma lipoproteins, platelet aggregability and prevalent ischaemic heart disease in eastern Finnish men. Atherosclerosis 1988; 70: 155–165
   PubMed Web of Science ®Google Scholar
• Riemersma R. A., Oliver M., Elton R. A., Alfthan G., Vartiainen E., Salo M., Rubba P., Mancini M., Georgi Vuilleumier J.-P., Grey K. F. Plasma antioxidants and coronary heart disease: vitamins C and E, and selenium. European Journal of Clinical Nutrition 1990; 44: 143–150
   PubMed Web of Science ®Google Scholar
• Riemersma R. A., Wood D. A., Macintyre C CA., Elton R. A., Grey K. F., Oliver M. F. Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene. Lancet 1991; 337: 1–5
   PubMed Web of Science ®Google Scholar
• Regnström J., Nilsson J., Tornvall P., Landou C., Hamsten A. Angiographic evidence for an association between susceptibility to low density lipoprotein oxidation and coronary atherosclerosis. Lancet 1992; 339: 1183–1186
   PubMed Web of Science ®Google Scholar